SB2510: RAPID Reserve Act Rolling Active Pharmaceutical Ingredient and Drug Reserve Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
A bill to improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
Plain-language summary
The RAPID Reserve Act would create stockpiles of critical drugs and their raw ingredients to protect against supply shortages and public health emergencies. The bill targets drugs with fragile supply chains that are vulnerable to disruptions. It aims to ensure these reserves are maintained and ready during drug shortages or crises. The bill has been introduced in Congress and is currently under consideration.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
SB2510: RAPID Reserve Act Rolling Active Pharmaceutical Ingredient and Drug Reserve Act
Upcoming hearings & events
Sponsors
Gary Peters
Primary SponsorCo-sponsors (5)
Sherrod Brown
Marsha Blackburn
Ted Budd
Peter Welch
Joni Ernst